Moolec Science (MLEC) Operating Expenses (2022 - 2024)
Moolec Science's (MLEC) quarterly Operating Expenses came in at -$1.2 million in Q4 2024, up 44.93% year-on-year from -$829495.0 in Q1 2024, and up 38.84% quarter-over-quarter from -$2.0 million in Q3 2024.
Moolec Science (MLEC) Operating Expenses (2022 - 2024) Analysis & Trends
Moolec Science has disclosed Operating Expenses across 3 years of filings, most recently posting -$1.2 million for Q4 2024.
- Operating Expenses for Q4 2024 came in at -$1.2 million, up 44.93% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 million (changed N/A YoY), and the FY2024 annual result was -$143.8 million, down 8.52% from the prior year.
- Operating Expenses came in at -$1.2 million for Q4 2024 at Moolec Science, up from -$2.0 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $358845.0 in Q1 2023 to a low of -$143.8 million in Q2 2024.
- The 3-year median for Operating Expenses is -$2.1 million (2023), against an average of -$31.9 million.
- Across the five-year window, Operating Expenses jumped 364.76% in 2023 and slumped 673.89% in 2024, its largest moves.
- Moolec Science's Operating Expenses stood at -$4.5 million in 2022, then soared by 51.5% to -$2.2 million in 2023, then jumped by 44.93% to -$1.2 million in 2024.
- The last three Operating Expenses figures came in at -$1.2 million (Q4 2024), -$2.0 million (Q3 2024), and -$143.8 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 15.76 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -67.40 Mn |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.20 Mn |
| Sep 30, 2024 | -1.97 Mn |
| Jun 30, 2024 | -143.76 Mn |
| Mar 31, 2024 | -2.06 Mn |
| Dec 31, 2023 | -2.18 Mn |
| Sep 30, 2023 | -2.21 Mn |
| Jun 30, 2023 | -132.48 Mn |
| Mar 31, 2023 | 358,845.00 |
| Dec 31, 2022 | -4.50 Mn |
| Sep 30, 2022 | -687,497.00 |
| Jun 30, 2022 | -91.72 Mn |
| Mar 31, 2022 | -135,536.00 |